The impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor, and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBozkurt, Mustafa
dc.contributor.authorOkutur, Kerem
dc.contributor.authorAydin, Kubra
dc.contributor.authorNamal, Esat
dc.contributor.authorOzturk, Akin
dc.contributor.authorPlanci, Kazman Nur
dc.contributor.authorHancer, Veysel Sabri
dc.contributor.authorTecimer, Coskun
dc.contributor.authorKucukkaya, Reyhan Diz
dc.contributor.authorDemir, Gokhan
dc.date.accessioned2025-10-16T15:33:03Z
dc.date.issued2014
dc.description.abstract50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, MAY 30-JUN 03, 2014
dc.identifier.doi10.1200/jco.2014.32.15\_suppl.e22049
dc.identifier.otherWOS:000358613201787
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9207
dc.publisherLIPPINCOTT WILLIAMS \& WILKINS
dc.sourceJOURNAL OF CLINICAL ONCOLOGY
dc.titleThe impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor, and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS